Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 9 of 9 citing Hogg: Identification of lesion components that influence visual function in age related macular.... (0.09 sec) 

Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal …


JS Slakter, T Bochow, DJ D'Amico, B Marks, J … - Ophthalmology, 2006 - Elsevier
Portions of the data were presented at: American Academy of Ophthalmology
meeting, October, 2004; New Orleans, Louisiana, and Macula Society meeting,
February, 2005; Key Biscayne, Florida. ... 1 Vitreous-Retina-Macula ...
Cited by 60 - Related articles - All 3 versions

Cardiovascular disease and hypertension are strong risk factors for choroidal …


RE Hogg, JV Woodside, SECM Gilchrist, R … - Ophthalmology, 2008 - Elsevier
Cited by 15 - Related articles - All 3 versions

Prevalence of patients presenting with neovascular age-related macular degeneration in an …


C Zawinka, E Ergun, M Stur - Retina, 2005 - journals.lww.com
This study was performed to determine the num- ber, type, and treatment
eligibility of new cases of neovascular age-related macular degeneration in an
urban population. Our results show that the introduc- tion of verteporfin ...
Cited by 10 - Related articles - All 2 versions

Visual acuity and its decrease in classic neovascular age-related macular degeneration


C Behrendt - Neuro-Ophthalmology, 2004 - informahealthcare.com
Correspondence and reprint requests to: Carolyn Behrendt, Ph.D. Pfizer Global
Research & Development 11085 Torreyana Road San Diego, CA 92121 USA Fax:
+1-(858) 678-8284 E-mail: carolynbehrendt@yahoo.com
Cited by 4 - Related articles - All 4 versions

Quantitative fluorescein angiographic analysis of choroidal neovascular membranes: …

- iovs.org
U Chakravarthy, AC Walsh, A Muldrew, PG … - Investigative ophthalmology & visual science, 2007 - ARVO
METHODS. Custom quantitative fluorescein analysis (QFA) software was used to
analyze 62 angiograms from patients with CNV for whom distance visual acuity
(DVA) data were available. On applying QFA, we obtained three mathematical ...
Cited by 3 - Related articles - BL Direct - All 3 versions

Visual acuity and structural findings in old age-related macular degeneration


A Riusala, S Sarna, I Immonen - Graefe's Archive for Clinical and Experimental …, 2005 - Springer
Abstract Background: Although exudative age-related macular degen- eration (AMD)
leads to a substantial visual loss in most patients there is still significant
variation in the end- stage visual acuity level. We analysed lesions in ...
Cited by 2 - Related articles - BL Direct - All 4 versions

Preclinical Evaluation of the Novel Small-Molecule Integrin {alpha} 5 {beta} 1 Inhibitor …


G Zahn, D Vossmeyer, R Stragies, M Wills, CG … - Archives of Ophthalmology, 2009 - Am Med Assoc
Methods JSM6427 selectivity for 5β1 was evaluated by in vitro binding assays
while the ability of JSM6427 to inhibit CNV was investigated in a laser-induced
monkey model and a growth factor–induced rabbit model. Intravitreal ...
Related articles - All 3 versions

Psychophysical Function in Age-related Maculopathy


K Neelam, J Nolan, U Chakravarthy, S Beatty - Survey of Ophthalmology, 2009 - Elsevier
Age-related macular degeneration (AMD), the late stage of age-related
maculopathy (ARM), is the leading cause of blind registration in developed
countries. The visual loss in AMD occurs due to dysfunction and death of ...
Related articles - All 17 versions

Visual acuity and its decrease in classic neovascular age-related macular degeneration …


O Epidemiology - Ophthalmic Epidemiology, 2004 - Informa Pharma Science
Correspondence and reprint requests to: Carolyn Behrendt, Ph.D. Pfizer Global
Research & Development 11085 Torreyana Road San Diego, CA 92121 USA Fax:
+1-(858) 678-8284 E-mail: carolynbehrendt@yahoo.com
Related articles


 


Go to Google Home - About Google - About Google Scholar

©2009 Google